Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
Titel:
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
Auteur:
O’Brien, Mary Paz-Ares, Luis Marreaud, Sandrine Dafni, Urania Oselin, Kersti Havel, Libor Esteban, Emilio Isla, Dolores Martinez-Marti, Alex Faehling, Martin Tsuboi, Masahiro Lee, Jong-Seok Nakagawa, Kazuhiko Yang, Jing Samkari, Ayman Keller, Steven M Mauer, Murielle Jha, Nitish Stahel, Rolf Besse, Benjamin Peters, Solange